Compare NBIX & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | BILI |
|---|---|---|
| Founded | 1992 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.1B |
| IPO Year | 1996 | N/A |
| Metric | NBIX | BILI |
|---|---|---|
| Price | $130.69 | $25.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 7 |
| Target Price | ★ $175.27 | $31.15 |
| AVG Volume (30 Days) | 901.1K | ★ 2.2M |
| Earning Date | 05-04-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.95 | N/A |
| EPS | ★ 4.67 | N/A |
| Revenue | ★ $161,626,000.00 | N/A |
| Revenue This Year | $22.85 | $11.00 |
| Revenue Next Year | $9.99 | $8.92 |
| P/E Ratio | ★ $27.99 | $122.37 |
| Revenue Growth | ★ 977.51 | N/A |
| 52 Week Low | $84.23 | $14.47 |
| 52 Week High | $160.18 | $36.40 |
| Indicator | NBIX | BILI |
|---|---|---|
| Relative Strength Index (RSI) | 48.44 | 40.30 |
| Support Level | $128.03 | $24.23 |
| Resistance Level | $136.74 | $25.67 |
| Average True Range (ATR) | 2.86 | 0.83 |
| MACD | 0.33 | -0.02 |
| Stochastic Oscillator | 47.92 | 26.11 |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.